title: [New methods of uterine fibroids treatment].
abstract: Uterine fibroids are the most common benign tumors of the uterus. Their main symptoms are prolonged menstrual bleeding, leading over time to a secondary anemia, bleeding and spotting between periods, pelvic pain and infertility. It is recognized that fibroids are the most common indication for surgery in gynecology. Currently radical surgical treatment of fibroids is abandon. Ulipristalu acetate is used in pharmacological treatment. This medicine reduces the growth of fibroids. New non-invasive technique is also MR-guided focused ultrasound surgery using thermal tissue destruction by focusing ultrasound beam. Ability to avoid the often crippling surgery makes conservative methods increasingly popular.
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Marciniak
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Iwona
authors.initials: I
authors.lastname: Szydłowska
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Brodowska
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Berenika
authors.initials: B
authors.lastname: Wiśniewska
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Nawrocka-Rutkowska
authors.affiliation: Pomeranian Medical University in Szczecin, Department of Gynecology, Endocrinology and Gynecologic Oncology.
authors.forename: Andrzej
authors.initials: A
authors.lastname: Starczewski
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D057086:High-Intensity Focused Ultrasound Ablation; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D009649:Norpregnadienes / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D009649:Norpregnadienes; C555622:ulipristal acetate
keywords: conservative treatment; uterine fibroids